Detail
Článek
Článek online
FT
Medvik - BMČ
  • Je něco špatně v tomto záznamu ?

Informing prostate cancer screening policy makers in the European Union: lessons from cancer screening governance and policymaking

S. Collen, A. Chandran, P. Guglielmetti, O. Májek, MJ. Roobol, H. Van Poppel, S. Torres-Rueda

. 2025 ; 35 (3) : 440-446. [pub] 20250601

Jazyk angličtina Země Anglie, Velká Británie

Typ dokumentu časopisecké články, systematický přehled

Perzistentní odkaz   https://www.medvik.cz/link/bmc25015409

Grantová podpora
001 World Health Organization - International
European Association of Urology Policy Office
European Association of Urology

Prostate cancer (PCa) poses a significant global health threat, with high incidence and mortality rates. In 2022, the Council of the European Union (EU) updated its screening recommendations, prioritizing PCa screening. This signals a crucial step towards establishing new early detection programmes in EU member states. This study investigates the role of policy makers and governance in cancer screening to inform the development of PCa screening. We had a mixed-method study design. First, a rapid review was conducted on policy making and governance in EU-funded cancer screening initiatives. Second, a focus group discussion reviewed study concepts and methods. Third, a systematic literature review was performed and, fourth, a series of in-depth interviews with actors involved in PCa screening pilots was conducted. Data were analysed thematically and the findings are used to propose 10 recommendations for policy makers. The results of the rapid review and focus group discussion framed the study in the context of existing cancer screening programmes across the EU, and highlighted what already exists in terms of governance tools and methodology. The literature review and in-depth interviews presented key learnings from the literature and real-life settings. These findings are reported using a pre-existing conceptional framework for effective health system governance. The study underscores the critical importance of governance in effective cancer screening programmes. Ten recommendations are proposed, including: defining cancer screening governance, allocating budgets and defining common approaches and key performance indicators for evaluation, establishing methods to enhance citizen participation, and reinforcing network governance.

Citace poskytuje Crossref.org

000      
00000naa a2200000 a 4500
001      
bmc25015409
003      
CZ-PrNML
005      
20250731090948.0
007      
ta
008      
250708s2025 enk f 000 0|eng||
009      
AR
024    7_
$a 10.1093/eurpub/ckaf066 $2 doi
035    __
$a (PubMed)40478531
040    __
$a ABA008 $b cze $d ABA008 $e AACR2
041    0_
$a eng
044    __
$a enk
100    1_
$a Collen, Sarah $u Policy Office , European Association of Urology, Arnhem, The Netherlands
245    10
$a Informing prostate cancer screening policy makers in the European Union: lessons from cancer screening governance and policymaking / $c S. Collen, A. Chandran, P. Guglielmetti, O. Májek, MJ. Roobol, H. Van Poppel, S. Torres-Rueda
520    9_
$a Prostate cancer (PCa) poses a significant global health threat, with high incidence and mortality rates. In 2022, the Council of the European Union (EU) updated its screening recommendations, prioritizing PCa screening. This signals a crucial step towards establishing new early detection programmes in EU member states. This study investigates the role of policy makers and governance in cancer screening to inform the development of PCa screening. We had a mixed-method study design. First, a rapid review was conducted on policy making and governance in EU-funded cancer screening initiatives. Second, a focus group discussion reviewed study concepts and methods. Third, a systematic literature review was performed and, fourth, a series of in-depth interviews with actors involved in PCa screening pilots was conducted. Data were analysed thematically and the findings are used to propose 10 recommendations for policy makers. The results of the rapid review and focus group discussion framed the study in the context of existing cancer screening programmes across the EU, and highlighted what already exists in terms of governance tools and methodology. The literature review and in-depth interviews presented key learnings from the literature and real-life settings. These findings are reported using a pre-existing conceptional framework for effective health system governance. The study underscores the critical importance of governance in effective cancer screening programmes. Ten recommendations are proposed, including: defining cancer screening governance, allocating budgets and defining common approaches and key performance indicators for evaluation, establishing methods to enhance citizen participation, and reinforcing network governance.
650    _2
$a lidé $7 D006801
650    12
$a nádory prostaty $x diagnóza $7 D011471
650    _2
$a mužské pohlaví $7 D008297
650    12
$a časná detekce nádoru $x metody $7 D055088
650    _2
$a Evropská unie $7 D005062
650    12
$a vytváření politiky $7 D011050
650    12
$a zdravotní politika $7 D006291
650    _2
$a zjišťování skupinových postojů $7 D017144
650    12
$a správní úředníci $7 D000288
650    12
$a plošný screening $x organizace a řízení $7 D008403
655    _2
$a časopisecké články $7 D016428
655    _2
$a systematický přehled $7 D000078182
700    1_
$a Chandran, Arunah $u International Agency for Research on Cancer/World Health Organization, Lyon, France
700    1_
$a Guglielmetti, Paolo $u Former: European Commission's Directorate-General for Health and Food Safety (DG SANTE), Luxembourg
700    1_
$a Májek, Ondřej $u National Screening Centre, Institute of Health Information and Statistics of the Czech Republic, Prague, Czech Republic $u Institute of Biostatistics and Analyses, Faculty of Medicine, Masaryk University, Brno, Czech Republic
700    1_
$a Roobol, Monique J $u Department of Urology, Erasmus MC Cancer Institute, Erasmus University Medical Center Rotterdam, The Netherlands
700    1_
$a Van Poppel, Hendrik $u Policy Office , European Association of Urology, Arnhem, The Netherlands $u Department of Urology, KU Leuven, Leuven, Belgium
700    1_
$a Torres-Rueda, Sergio $u London School of Hygiene and Tropical Medicine, London, United Kingdom
773    0_
$w MED00012099 $t European journal of public health $x 1464-360X $g Roč. 35, č. 3 (2025), s. 440-446
856    41
$u https://pubmed.ncbi.nlm.nih.gov/40478531 $y Pubmed
910    __
$a ABA008 $b sig $c sign $y - $z 0
990    __
$a 20250708 $b ABA008
991    __
$a 20250731090942 $b ABA008
999    __
$a ok $b bmc $g 2366317 $s 1252534
BAS    __
$a 3
BAS    __
$a PreBMC-MEDLINE
BMC    __
$a 2025 $b 35 $c 3 $d 440-446 $e 20250601 $i 1464-360X $m European journal of public health $n Eur J Public Health $x MED00012099
GRA    __
$a 001 $p World Health Organization $2 International
GRA    __
$p European Association of Urology Policy Office
GRA    __
$p European Association of Urology
LZP    __
$a Pubmed-20250708

Najít záznam

Citační ukazatele

Možnosti archivace